『bright red blood - the irreverent MD』のカバーアート

bright red blood - the irreverent MD

bright red blood - the irreverent MD

著者: Sam
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

An evidence-based medicine podcast to separate the gems from the crap for all.

© 2026 bright red blood - the irreverent MD
衛生・健康的な生活 身体的病い・疾患
エピソード
  • You can't outrun cancer... or can you...
    2026/04/24

    First there is more fun on the Oncology service to be had by all. Then we discuss a landmark trial assessing the benefit of exercise as adjunctive therapy for colon cancer.

    Most pertinent articles:

    Bozzetti F. Potential Benefits from Physical Exercise in Advanced Cancer Patients Undergoing Systemic Therapy? A Narrative Review of the Randomized Clinical Trials. Curr Oncol. 2024 Dec 1;31(12):7631-7646.

    Courneya KS, Vardy JL, O'Callaghan CJ, Gill S, Friedenreich CM, Wong RKS, Dhillon HM, Coyle V, Chua NS, Jonker DJ, Beale PJ, Haider K, Tang PA, Bonaventura T, Wong R, Lim HJ, Burge ME, Hubay S, Sanatani M, Campbell KL, Arthuso FZ, Turner J, Meyer RM, Brundage M, O'Brien P, Tu D, Booth CM; CHALLENGE Investigators. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. N Engl J Med. 2025 Jul 3;393(1):13-25.

    Feng Y, Feng X, Wan R, Luo Z, Qu L, Wang Q. Impact of exercise on cancer: mechanistic perspectives and new insights. Front Immunol. 2024 Sep 13;15:1474770.

    Zylstra J, Whyte GP, Beckmann K, Pate J, Santaolalla A, Gervais-Andre L, Russell B, Maisey N, Waters J, Tham G, Lagergren J, Green M, Kelly M, Baker C, Van Hemelrijck M, Goh V, Gossage J, Browning M, Davies A. Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial. Br J Sports Med. 2022 Apr;56(7):402-409.

    続きを読む 一部表示
    29 分
  • 6 paltry nuisances and the histrionic ire they beget...
    2026/04/10

    Join me as I first discuss annoying people, followed by a lot of annoying Medicine.


    Bajaj JS, Pyrsopoulos NT, Rahimi RS, Heimanson Z, Allen C, Rockey DC. Serum Ammonia Levels Do Not Correlate With Overt Hepatic Encephalopathy Severity in Hospitalized Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2024 Sep;22(9):1950-1952.e1.

    Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet. 2004 Nov 6-12;364(9446):1684-9.

    Espinel CH. The FENa test. Use in the differential diagnosis of acute renal failure. JAMA. 1976 Aug 9;236(6):579-81.

    Hirota T, Fujita Y, Ieiri I. An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins. Expert Opin Drug Metab Toxicol. 2020 Sep;16(9):809-822.

    Osa-Andrews B, Sanchez M, Hashim IA. The Continued Need for the Routine Assessment of Folate Status. Lab Med. 2023 Jul 5;54(4):424-428.

    Pan HC, Jiang ZH, Chen HY, Liu JH, Chen YW, Peng KY, Wu VC, Hsiao CC. Assessing the utility of fractional excretion of urea in distinguishing intrinsic and prerenal acute kidney injury in hospitalised patients: a systematic review and meta-analysis. BMJ Open. 2026 Jan 14;16(1):e100875.

    Ripley TL, Saseen JJ. β-blockers: a review of their pharmacological and physiological diversity in hypertension. Ann Pharmacother. 2014 Jun;48(6):723-33.

    Sobczyńska-Malefora A, Harrington DJ. Laboratory assessment of folate (vitamin B9) status. J Clin Pathol. 2018 Nov;71(11):949-956.

    Varghese V, Rivera MS, Alalwan A, Alghamdi AM, Ramanand A, Khan SM, Najul-Seda JE, Velez JCQ. Concomitant Identification of Muddy Brown Granular Casts and Low Fractional Excretion of Urinary Sodium in AKI. Kidney360. 2022 Jan 19;3(4):627-635.

    Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017 Jan 20;1(1):CD002003.

    続きを読む 一部表示
    27 分
  • What not to do with bloody poo...
    2026/03/27

    After arguing that Geriatrics really is a worthy subspecialty, I recount all of the poop I just can’t get away from… even after the patient is technically dead… Then prepare to be bombarded by the mounting evidence against and festering frustration with fecal occult blood tests being used just for funzies.

    Lee MW, Pourmorady JS, Laine L. Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2020 May;115(5):662-670.

    Bhatti U, Jansson-Knodell C, Saito A, Han A, Krajicek E, Han Y, Imperiale TF, Fayad N. Not FIT for Use: Fecal Immunochemical Testing in the Inpatient and Emergency Settings. Am J Med. 2022 Jan;135(1):76-81.

    Román-Colón D, Rodriguez-Ramos R, Cerra-Franco J, De Jesús-De La Cruz H, Mirza ZT, Cepero-Jimenez C, Ramos-Marquez R, Martinez-Souss J, Toro DH. The Use of the Fecal Immunochemical Test in the Acute-Care Hospital Setting. P R Health Sci J. 2025 Dec;44(4):189-194.

    続きを読む 一部表示
    24 分
まだレビューはありません